In fact, high levels of PGE2 in the tumor resulting from the aberrant activation of COX-2 are commonly considered as indicators of a poorer cancer prognosis in different types of malignancies such as melanoma, breast, colon, lung, or gastric cancer17. This evidence concerns the gene PTGS2 and neoplasm.